Inserm is involved in partnerships with private players in the field of research and has strong partnerships with national and international industrial companies including Dassault Systèmes, MSD Avenir, MedImmune/AstraZeneca, Sanofi and Pierre Fabre.
Partnerships between Inserm and industry rely on the know-how of Inserm Transfert. This private subsidiary of Inserm manages the implementation and transfer of knowledge from Inserm's research laboratories to industry, helping to promote health innovation.
Industrial partnerships: 2018 figures
- 82 license agreements
- 300 R&D agreements